Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $3.6B |
| Sales growthchange from the year before | -13.1% |
| Gross marginshare of sales left after the direct cost of what it sells | 23.9% |
| Operating marginshare of sales left after running the business | 10.7% |
| Net marginshare of sales kept as profit | 9.4% |
| Free-cash-flow marginspare cash generated per $100 of sales | 11.5% |
| Return on invested capitalprofit made on each $100 put into the business | 5.4% |
| Return on equityprofit vs. shareholders' accounting value | 10.8% |
| Debt / equitydebt vs. shareholders' accounting value | 0.79 |
| Change in share countnegative = the company is buying back its shares | -8.3% |
1 insider bought $983K; 1 insider sold $39K (all under pre-arranged plans) on the open market.
| Root Jonathan RCFO and CCO | Sold (plan)Aug 3 | 1,554 shat $24.88 · $39K |
| Nova Daniel JDirector | BoughtJul 31 | 40,000 shat $24.57 · $983K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy